chrysoidine C10-14-alkyl derivatives; benzenesulfonic acid, mono-C10-14-alkyl derivatives, compounds with 4-(phenylazo)-1,3-benzenediamine [1] chrysoidine compound with dibutylnaphthalene sulfonic acid; dibutylnaphthalenesulfonic acid, compound with 4-(phenylazo)benzene-1,3-diamine (1:1) [2]

chrysoidine C10-14-alkyl derivatives; benzenesulfonic acid, mono-C10-14-alkyl derivatives, compounds with 4-(phenylazo)-1,3-benzenediamine [1] chrysoidine compound with dibutylnaphthalene sulfonic acid; dibutylnaphthalenesulfonic acid, compound with 4-(phenylazo)benzene-1,3-diamine (1:1) [2] is corrosive to skin, eyes, or metals. Store in acid-resistant or alkali-resistant cabinets as appropriate. Do not store in metal containers. Secondary containment (drip trays) is required. Segregate from incompatible substances such as strong oxidisers.

chrysoidine C10-14-alkyl derivatives; benzenesulfonic acid, mono-C10-14-alkyl derivatives, compounds with 4-(phenylazo)-1,3-benzenediamine [1] chrysoidine compound with dibutylnaphthalene sulfonic acid; dibutylnaphthalenesulfonic acid, compound with 4-(phenylazo)benzene-1,3-diamine (1:1) [2] may cause irritation to skin, eyes, or respiratory tract, or has low-level systemic toxicity. Adequate ventilation must be provided in work areas. Personal protective equipment (gloves, eye protection) is recommended during handling.

chrysoidine C10-14-alkyl derivatives; benzenesulfonic acid, mono-C10-14-alkyl derivatives, compounds with 4-(phenylazo)-1,3-benzenediamine [1] chrysoidine compound with dibutylnaphthalene sulfonic acid; dibutylnaphthalenesulfonic acid, compound with 4-(phenylazo)benzene-1,3-diamine (1:1) [2] is classified as mutagenic. Exposure must be minimised using engineering controls (local exhaust ventilation, closed systems). Biological and medical monitoring may be required. Refer to the full Safety Data Sheet (SDS) Section 8 for occupational exposure limits.

This substance carries the signal word DANGER, indicating the more severe hazard categories under GHS/CLP. Facilities handling chrysoidine C10-14-alkyl derivatives; benzenesulfonic acid, mono-C10-14-alkyl derivatives, compounds with 4-(phenylazo)-1,3-benzenediamine [1] chrysoidine compound with dibutylnaphthalene sulfonic acid; dibutylnaphthalenesulfonic acid, compound with 4-(phenylazo)benzene-1,3-diamine (1:1) [2] should ensure a written hazard communication programme, including current SDS, employee training records, and GHS-compliant labelling on all containers.